AMGEN INC — Director's Dealing 2016

Apr 28, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2016-04-26

Reporting Person: Tross Stuart A (SVP, Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-26	Common Stock	F	181	$163.46	Disposed	23879	Direct
2016-04-27	Common Stock	F	254	$162.85	Disposed	23625	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	593.142	Indirect

Footnotes

F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 334 RSUs which vest on 4/26/2017; 2,131 RSUs which vest in one installment of 1,049 on 10/25/2016 and one installment of 1,082 on 10/25/2017; 1,127 RSUs which vest in two installments of 555 and 572 on 1/31/2017 and 1/31/2018, respectively; and 1,576 RSUs which vest in two equal installments of 520 on 1/30/2017 and 1/30/2018 and one installment of 536 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2: These shares include 225 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

F3: These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.